| Meta-and orthogonal integration of influenza “OMICs” data defines a role for UBR4 in virus budding S Tripathi, MO Pohl, Y Zhou, A Rodriguez-Frandsen, G Wang, DA Stein, ... Cell host & microbe 18 (6), 723-735, 2015 | 931 | 2015 |
| Zika virus targets human STAT2 to inhibit type I interferon signaling A Grant, SS Ponia, S Tripathi, V Balasubramaniam, L Miorin, ... Cell host & microbe 19 (6), 882-890, 2016 | 870 | 2016 |
| Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity SV Bardina, P Bunduc, S Tripathi, J Duehr, JJ Frere, JA Brown, ... Science 356 (6334), 175-180, 2017 | 582 | 2017 |
| Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection S Aguirre, P Luthra, MT Sanchez-Aparicio, AM Maestre, J Patel, ... Nature microbiology 2 (5), 1-11, 2017 | 387 | 2017 |
| Comparative flavivirus-host protein interaction mapping reveals mechanisms of dengue and Zika virus pathogenesis PS Shah, N Link, GM Jang, PP Sharp, T Zhu, DL Swaney, JR Johnson, ... Cell 175 (7), 1931-1945. e18, 2018 | 298 | 2018 |
| A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses S Tripathi, VRMT Balasubramaniam, JA Brown, I Mena, A Grant, ... PLoS pathogens 13 (3), e1006258, 2017 | 256 | 2017 |
| An immunocompetent mouse model of Zika virus infection MJ Gorman, EA Caine, K Zaitsev, MC Begley, J Weger-Lucarelli, ... Cell host & microbe 23 (5), 672-685. e6, 2018 | 233 | 2018 |
| Targeting viral proteostasis limits influenza virus, HIV, and dengue virus infection NS Heaton, N Moshkina, R Fenouil, TJ Gardner, S Aguirre, PS Shah, ... Immunity 44 (1), 46-58, 2016 | 137 | 2016 |
| Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection R Narayan, S Tripathi Frontiers in cellular and infection microbiology 10, 580096, 2020 | 115 | 2020 |
| Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation K Sharma, S Tripathi, P Ranjan, P Kumar, R Garten, V Deyde, JM Katz, ... PloS one 6 (6), e20215, 2011 | 112 | 2011 |
| Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin S Tripathi, J Batra, W Cao, K Sharma, JR Patel, P Ranjan, A Kumar, ... Cell death & disease 4 (3), e562-e562, 2013 | 110 | 2013 |
| Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs V Tran, MP Ledwith, T Thamamongood, CA Higgins, S Tripathi, ... Nature microbiology 5 (12), 1490-1503, 2020 | 64 | 2020 |
| Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins J Batra, S Tripathi, A Kumar, JM Katz, NJ Cox, RB Lal, S Sambhara, ... Scientific reports 6 (1), 19063, 2016 | 62 | 2016 |
| The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response LL Seifert, C Si, D Saha, M Sadic, M de Vries, S Ballentine, A Briley, ... PLoS pathogens 15 (11), e1007634, 2019 | 54 | 2019 |
| Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication S Sharma, AK Mayank, H Nailwal, S Tripathi, JR Patel, JB Bowzard, ... The FEBS Journal 281 (13), 2899-2914, 2014 | 48 | 2014 |
| Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples A Biji, O Khatun, S Swaraj, R Narayan, RS Rajmani, R Sardar, D Satish, ... EBioMedicine 70, 2021 | 38 | 2021 |
| Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2 M Afsar, R Narayan, MN Akhtar, D Das, H Rahil, SK Nagaraj, ... Elife 11, e74877, 2022 | 36 | 2022 |
| Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease S Bhagat, N Yadav, J Shah, H Dave, S Swaraj, S Tripathi, S Singh Expert Review of Anti-Infective Therapy 20 (10), 1275-1298, 2022 | 35 | 2022 |
| Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation S Soonthornvacharin, A Rodriguez-Frandsen, Y Zhou, F Galvez, ... Nature microbiology 2 (5), 1-13, 2017 | 35 | 2017 |
| Moving from empirical to rational vaccine design in the ‘Omics’ Era M Sharma, F Krammer, A García-Sastre, S Tripathi Vaccines 7 (3), 89, 2019 | 34 | 2019 |
